BioLineRx Ltd. (TLV:BLRX)
1.300
0.00 (0.00%)
Sep 10, 2026, 5:28 PM IDT
BioLineRx Employees
As of December 31, 2025, BioLineRx had 24 total employees, including 20 full-time and 4 part-time employees. The number of employees decreased by 4 or -14.29% compared to the previous year.
Employees
24
Change (1Y)
-4
Growth (1Y)
-14.29%
Revenue / Employee
188.50K ILS
Profits / Employee
-946.41K ILS
Market Cap
34.07M
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) | Full-Time | Part-Time |
|---|---|---|---|---|---|
| Dec 31, 2025 | 24 | -4 | -14.29% | 20 | 4 |
| Dec 31, 2024 | 28 | -51 | -64.56% | 24 | 4 |
| Dec 31, 2023 | 79 | 30 | 61.22% | 79 | 0 |
| Dec 31, 2022 | 49 | 11 | 28.95% | 49 | 0 |
| Dec 31, 2021 | 38 | 0 | - | 38 | 0 |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
Related Stocks
| Company Name | Employees |
|---|---|
| Bonus BioGroup | 42 |
| Evogene | 38 |
| Matricelf | 15 |
| Purple Biotech | 10 |
| XTL Biopharmaceuticals | 5 |
| Can-Fite BioPharma | 5 |
| BioLight Life Sciences | 4 |
BioLineRx News
- 3 days ago - BioLineRx and Hemispherian AS to Present Encouraging GLIX1 Preclinical Efficacy Data and its Phase 1/2a Trial Design at the 21st Meeting of the European Association of Neuro-Oncology (EANO 2026) - PRNewsWire
- 13 days ago - BioLineRx Releases Q2 2026 Financial Results - AlphaStreet
- 13 days ago - BioLineRx Earnings Call Transcript: Q2 2026 - Transcripts
- 13 days ago - BioLineRx Earnings release: Q2 2026 - Filings
- 13 days ago - BioLineRx reports Q2 EPS 0c vs 0c last year - TheFly
- 13 days ago - BioLineRx Reports Second Quarter 2026 Financial Results and Provides Corporate Update - PRNewsWire
- 16 days ago - BioLineRx prices 1.35M ADSs at $2.78 in registered direct offering - TheFly
- 16 days ago - BioLineRx Announces $3.75 Million Registered Direct Offering and Concurrent Private Placement - PRNewsWire